FDA Says Generic Wellbutrin Not As Effective

In an unusual move, the FDA asks for voluntary recall of popular generic antidepressant.

 

The FDA’s reversal earlier this week of its approval of a generic equivalent of the popular antidepressant Wellbutrin XL 300 ends a five-year saga that began with consumer complaints and a crusade by Joe Graedon, the cofounder of the consumer advocacy group the People’s Pharmacy.

 Read the rest of this article here »